Drug Development/R&D
New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.
Pharmaceutical Research: the Case for Growth in Britain
1 July 1967
ONE of the problems in Britain today is that too little of its academic research is associated with successful innovation in industry. The result is that…
Science, Industry in the State
7 January 1965
Based on a series of six lectures discussing some of the special considerations which arise when a science based industry has the government as a major…
Finance of Medical Research
7 January 1964
The explosive progress of medical science during the past twenty-five years has brought about a revolution in the health of the community and in the problems…